Open Access 04.09.2020 | COVID-19 | Letter
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
Erschienen in: Trials | Ausgabe 1/2020
Open Access 04.09.2020 | COVID-19 | Letter
Erschienen in: Trials | Ausgabe 1/2020